PDS Planning Inc Has $769,000 Position in Danaher Co. (NYSE:DHR)

PDS Planning Inc lessened its holdings in Danaher Co. (NYSE:DHR) by 7.6% in the 4th quarter, HoldingsChannel.com reports. The firm owned 3,351 shares of the conglomerate’s stock after selling 277 shares during the quarter. PDS Planning Inc’s holdings in Danaher were worth $769,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in DHR. FMR LLC grew its stake in shares of Danaher by 15.8% in the 3rd quarter. FMR LLC now owns 23,617,424 shares of the conglomerate’s stock valued at $6,566,116,000 after purchasing an additional 3,217,631 shares during the period. Bank of New York Mellon Corp grew its stake in shares of Danaher by 5.4% in the 4th quarter. Bank of New York Mellon Corp now owns 8,589,019 shares of the conglomerate’s stock valued at $1,971,609,000 after purchasing an additional 441,012 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of Danaher by 3.0% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,097,986 shares of the conglomerate’s stock valued at $1,417,342,000 after purchasing an additional 148,251 shares during the period. Fisher Asset Management LLC grew its stake in shares of Danaher by 0.6% in the 4th quarter. Fisher Asset Management LLC now owns 4,578,945 shares of the conglomerate’s stock valued at $1,051,097,000 after purchasing an additional 26,305 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its stake in shares of Danaher by 3.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 4,066,755 shares of the conglomerate’s stock valued at $933,524,000 after purchasing an additional 135,047 shares during the period. Institutional investors own 79.05% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the company. Robert W. Baird lowered their price objective on Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Royal Bank of Canada restated an “outperform” rating and set a $277.00 price target (down from $299.00) on shares of Danaher in a research report on Thursday, January 30th. Barclays decreased their price target on Danaher from $275.00 to $240.00 and set an “equal weight” rating on the stock in a research report on Thursday, January 30th. Raymond James restated a “market perform” rating on shares of Danaher in a research report on Monday, February 3rd. Finally, The Goldman Sachs Group set a $250.00 price target on Danaher in a research report on Wednesday, January 15th. Six research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and a consensus price target of $277.76.

Insider Activity

In related news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the sale, the senior vice president now owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 11.10% of the stock is currently owned by company insiders.

Danaher Stock Performance

DHR stock opened at $212.78 on Tuesday. The business’s fifty day moving average is $219.57 and its 200-day moving average is $240.07. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The company has a market cap of $152.08 billion, a P/E ratio of 40.30, a price-to-earnings-growth ratio of 2.66 and a beta of 0.82. Danaher Co. has a twelve month low of $196.80 and a twelve month high of $281.70.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the prior year, the company posted $2.09 EPS. Equities research analysts forecast that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a $0.32 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.60%. This is an increase from Danaher’s previous quarterly dividend of $0.27. Danaher’s dividend payout ratio is 24.24%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.